Immune Support Stack: Thymosin Alpha-1 + Thymulin + KPV

The immune system is not a single dial to turn up. It's a network of cell populations, signaling molecules, and tissue-specific responses that need to be balanced, not boosted. Peptides framed as "immune boosters" are usually the ones selling the biggest oversimplification.

This stack is different. Thymosin alpha-1 and Thymulin are thymic peptides with real mechanistic grounding in T-cell maturation and immunomodulation. KPV is the inflammation-cooling piece. Together they're more of an immune-rebalancing tool than a "boost."

Who this is for

• Someone with a history of chronic low-grade infections (recurring sinus, UTIs, skin issues)
• Post-illness recovery where the immune system feels depleted (post-viral fatigue, post-mono presentations)
• Autoimmune-flavored dysregulation (under medical supervision only)
• Someone 50+ with age-related immune decline patterns showing up in labs or pattern of illness

Not for: acute infection (treat the infection first), active cancer, transplant recipients, or anyone on immunosuppressive medication without their doctor coordinating.

The compounds

• Thymosin Alpha-1 (Tα1) — 1.5 mg sub-Q, 2x per week. Run in 8-12 week courses.
• Thymulin — 100-200 mcg sub-Q, 3x per week
• KPV — 250-500 mcg sub-Q daily, or oral capsules (200-500 mcg) if targeting gut

Weekly schedule

Day	AM	PM
Mon	KPV 500 mcg + Tα1 1.5 mg	—
Tue	KPV 500 mcg + Thymulin 200 mcg	—
Wed	KPV 500 mcg	—
Thu	KPV 500 mcg + Tα1 1.5 mg	—
Fri	KPV 500 mcg + Thymulin 200 mcg	—
Sat	KPV 500 mcg	—
Sun	KPV 500 mcg + Thymulin 200 mcg	—

All sub-Q injections can go in the belly. They can share sites but alternate days.

Why the three together

Thymosin alpha-1 is a 28-amino-acid peptide originally isolated from the thymus. Its observed activity clusters around T-cell maturation and differentiation, NK cell function, and dendritic cell priming. It's been studied in viral illness recovery and — in some clinical literature outside the US — as an adjunctive therapy in immune-compromised states.

Thymulin is a nonapeptide also of thymic origin, zinc-dependent, involved in T-lymphocyte maturation at the thymic stage. Where Tα1 acts more on peripheral T-cell function, Thymulin signals further upstream in thymic development. Age-related thymic involution reduces Thymulin production, which is why the protocol leans on it more in older users.

KPV is the tripeptide fragment (Lys-Pro-Val) of alpha-MSH with potent anti-inflammatory activity. It's not strictly an immune booster — it's the inflammation-cooling piece that keeps the stack from being pro-inflammatory as it modulates T-cell populations.

Running all three addresses the maturation side (Thymulin), the function side (Tα1), and the inflammation context (KPV).

Ramp-up and cycling

No ramp is strictly necessary but conservative users start at half doses for the first week to confirm no adverse reactions.

Cycling: 8-12 weeks on, 4-8 weeks off. Immune peptides are well-tolerated long-term, but the community default is to rest between cycles rather than run indefinitely.

Thymosin alpha-1 in particular is dose-sensitive in the sense that more is not better. The 1.5 mg 2x/week dose is the standard research window. Pushing higher isn't backed by good data.

What to expect

• Week 1-2: Subtle. Possibly slightly elevated baseline energy. Some users note fewer "I feel like I'm getting sick" days.
• Week 3-4: Recovery from minor illness notably faster. Wound healing often improves in parallel (Tα1 has some tissue repair signaling).
• Week 6-8: Labs — if you're pulling CBC and immune markers — may show normalization patterns. Lymphocyte subset shifts are the most common observation.
• Post-cycle: Benefits tend to hold for weeks to months after stopping.

This stack does not feel like a drug. You don't get through a cold faster and realize in hindsight you've been running a subtler baseline.

Labs worth pulling

If you're running this seriously, baseline and post-cycle:

• CBC with differential
• CD4/CD8 ratio if accessible
• IgA, IgG, IgM
• hsCRP
• Vitamin D (immune cofactor)
• Zinc (important for Thymulin)

Cost ballpark

Thymosin alpha-1 is the expensive piece — $100-200 per 10 mg vial at community pricing. Thymulin is cheaper ($30-60 per vial). KPV is inexpensive. A 12-week full stack lands around $400-700.

Red flags — when to stop

• Any signs of autoimmune flare in someone with a predisposition — this is why medical supervision matters for autoimmune histories
• Persistent injection-site reactions
• New, unexplained lymph node swelling — investigate before continuing
• Any rash pattern that doesn't resolve — KPV is usually anti-inflammatory but individual responses vary

Where to go next

• The gut reset protocol overlaps heavily — KPV appears in both, and gut-immune axis work often runs together.
• For post-illness recovery specifically, the Pepperpedia immune reset protocol offers additional framing.
• Deeper mechanism: Pepperpedia Thymosin alpha-1, Thymulin, KPV.
• Real outcomes and lab changes in the Protocol Discussions forum.